<?xml version="1.0" encoding="UTF-8"?>
<div class="fig" id="PMC7102646/figure_2" xmlns="http://www.w3.org/1999/xhtml">
 <caption> Bar graph representing the binding energies (in kcal/mol) calculated by AutoDock Vina software for GTP, UTP, CTP, ATP, Cinnamaldehyde, Thymoquinone, Galidesivir, Remdesivir, Tenofovir, Sofosbuvir, Ribavirin, Uprifosbuvir, Setrobuvir, Balaprevir, MK0608, R7128, IDX-184, 2â€² C-methylcytidine, BMS-986094, YAK, PSI-6130, PSI-6206, R1479, and Valopectibine against SARS-CoV-2 RdRp (blue), SARS HCoV RdRp (orange), and HCV NS5B RdRp (gray). The dashed-red rectangles mark the best three compounds. The dashed green box marks the five drugs (approved by FDA against HCV, EBOV, and HIV). (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.) </caption>
 <div class="graphic"/>
 <p class="label">Fig. 2</p>
</div>
